Viewing Study NCT00023166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2026-01-28 @ 4:54 PM
Study NCT ID: NCT00023166
Status: TERMINATED
Last Update Posted: 2005-06-24
First Post: 2001-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas
Sponsor: Enzon Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasm View
None Lymphomas View
None Neoplasm Metastasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None Open label View
None Safety/efficacy View
None Lymphomas View
None Advanced primary and/or metastatic solid tumors View
None Neoplasms View
None Neoplasm metastasis View